discovery GmbH discovery combines single cell functional genomics with best-in-class cellular models to decipher complex cellular pathways and gain a better understanding of disease development. This next-generation CRISPR screening platform will help to understand the role of gene networks at unprecedented scale and resolution to discover and validate novel drug targets and generate deep knowledge on factors that drive the differentiation of stem cells into mature tissue.
By creating and utilising physiological relevant, pure and consistent human cell types, with matched disease models, discovery offers customers an ever expanding opportunity to perform CRISPR screens.